Cardiopulmonary Resuscitation Devices Market Size, Share, Industry, Forecast and outlook (2024-2031)

Global Cardiopulmonary Resuscitation Devices Market is segmented By Product Type (Automated External Defibrillators (AEDs), Manual External Defibrillators, Mechanical CPR Devices, Chest Compression Systems, Others) By Technology (Fully Automated CPR Devices, Semi-Automated CPR Devices) By Application (Cardiac Arrest, Respiratory Arrest, Trauma Cases, Others) By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Emergency Medical Services (EMS), Others) and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

Cardiopulmonary Resuscitation Devices Overview

The global Cardiopulmonary resuscitation devices reached US$ 2.62 billion in 2023 and is expected to reach US$ 4.07 billion by 2031, growing at a CAGR of 5.7% during the forecast period 2024-2031.

Cardiopulmonary resuscitation (CPR) devices are tools designed to assist in delivering effective chest compressions and, in some cases, providing ventilation during CPR procedures. These devices aim to enhance the quality and consistency of CPR, which is crucial for improving outcomes in cardiac arrest situations. CPR devices are designed to deliver consistent and high-quality chest compressions, ensuring that the correct compression rate, depth, and recoil are maintained. 

Consistency in CPR delivery is critical for maximizing blood flow to vital organs and improving the chances of restoring a normal heart rhythm. CPR devices help standardize the delivery of CPR across different rescuers and settings. This is particularly important in environments where multiple rescuers may be involved or where the quality of manual CPR may vary depending on factors such as rescuer experience and training.

Cardiopulmonary Resuscitation Devices Scope

For more details of the report - Request for sample

Cardiopulmonary Resuscitation Devices Dynamics: Drivers and Restraints

Increasing incidence of cardiac arrest

The rising prevalence of cardiovascular diseases and related risk factors contributes to a higher incidence of cardiac arrest cases globally. This increased incidence drives the demand for CPR devices as essential tools for resuscitation efforts. As the incidence of cardiac arrest rises, there is a corresponding increase in the demand for resuscitation equipment, including CPR devices.

For instance, according to CDC 2022, demonstrated that, more than 356,000 people have an out-of-hospital cardiac arrest in the United States every year, and about 60% to 80% of them die before reaching the hospital. Cardiac arrest occurs when the heart suddenly and unexpectedly stops beating. Blood stops flowing to the rest of the body.

Additionally, according to Singapore Heart Foundation, estimated that, in Singapore, more than 3,000 people suffer from sudden cardiac arrest every year, with more than 80% in residential and public settings, i.e. outside healthcare facilities. Moreover, the aging population demographic trend in many countries is associated with a higher incidence of cardiac arrest. Older adults are more susceptible to cardiovascular conditions and other comorbidities that increase the risk of sudden cardiac arrest.

Market Dynamics: Restraint

Training and education barriers

CPR devices are not only used in healthcare settings but also by laypersons and first responders in various public and community environments. However, the lack of accessible and comprehensive CPR training programs can hinder the adoption of CPR devices outside of healthcare settings. Without proper training, individuals may be hesitant or unsure about using CPR devices effectively during emergencies.Example: A community lacks CPR training initiatives for school staff, despite having automated external defibrillators (AEDs) installed in schools. 

Without proper training, teachers and staff may be reluctant to use the AEDs or CPR devices during cardiac emergencies, reducing their effectiveness in saving lives. Some CPR devices, especially those with advanced features or technologies, may require specialized training for proper operation. If training programs do not adequately cover the use of these devices or if training materials are not readily accessible, potential users may struggle to understand how to operate the devices correctly.

Cardiopulmonary Resuscitation Devices Segment Analysis

The global cardiopulmonary resuscitation devices market is segmented based on product type, technology, application, end-user and region.

The automated external defibrillators (AED) from the product type segment accounted for approximately 34.14% of share

Public awareness campaigns and initiatives aimed at educating communities about sudden cardiac arrest (SCA) and the importance of early defibrillation have contributed to increased demand for AEDs. Efforts to make AEDs more accessible in public places, such as airports, schools, sports facilities, and workplaces, have expanded the market for these devices. The rise of product launches and the awareness helps to boost the segment growth.

For instance, on January 23, 2023,  Avive Solutions, Inc., had received U.S. Food and Drug Administration (FDA) pre-market approval the agency’s highest level of approval for its Avive AED, a unique automated external defibrillator.  Additionally, in 2023, The Clemson University Fire & EMS Department (CUFD) and the Facilities Department had partnered to install new automated external defibrillators (AEDs) in key facilities-related locations in and around Clemson’s main campus. 

The new AEDs feature continuous self-monitoring to ensure the device is always rescue-ready. In addition, they are Wi-Fi enabled, allowing CUFD to monitor the devices remotely to view the status of the device, as well as battery and electrode information. Thus above factors helps to accelerates the market growth.

Cardiopulmonary Resuscitation Devices Geographical Analysis

North America accounted for approximately 41.21% of the market share in 2022

North America has a relatively high prevalence of cardiovascular diseases (CVDs), including coronary artery disease, hypertension, and heart failure. The increased incidence of cardiac events, such as sudden cardiac arrest (SCA), underscores the importance of CPR devices and AEDs in improving patient outcomes. Healthcare facilities in the region prioritize investment in resuscitation equipment to address the needs of patients at risk of cardiac emergencies, driving market growth.

For instance, according to CDC, stated that, heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States.  One person dies every 33 seconds in the United States from cardiovascular disease. About 695,000 people in the United States died from heart disease in 2021—that’s 1 in every 5 deaths. 

Additionally, North America is a hub for technological innovation and medical research, driving advancements in CPR and AED technologies. Research institutions, universities, and medical device companies collaborate to develop innovative solutions for improving resuscitation outcomes.

COVID-19 Impact Analysis On Cardiopulmonary Resuscitation Devices

With the surge in COVID-19 cases, there was a heightened need for CPR devices in hospitals and healthcare facilities. COVID-19 can cause severe respiratory distress and cardiac complications in some patients, necessitating the use of CPR to revive them. This increased demand put pressure on manufacturers to ramp up production to meet the needs of healthcare providers. The COVID-19 crisis highlighted the importance of emergency preparedness and response. 

Healthcare providers and institutions prioritized the acquisition of CPR devices and other emergency medical equipment to address the needs of patients, particularly those with severe COVID-19 symptoms. This shift in focus towards emergency response strategies influenced the demand for CPR devices in the market. The pandemic prompted increased research and development efforts in the healthcare industry, including innovations in medical devices and technologies.

Cardiopulmonary Resuscitation Devices Competitive Landscape

The major global players in the market include Stryker Corporation, Philips Healthcare, GE Healthcare, Schiller AG, ZOLL Medical Corporation, Ambu A/S, Cardiac Science Corporation, Nihon Kohden Corporation, Smiths Medical, Mindray Medical International Limited among others.

Key Developments

• In 2024, Stryker, had launched two new products: LIFEPAK CR2 automated external defibrillator (AED) for cardiac care and Evacuation Chair for emergency patient evacuation. The LIFEPAK CR2 is a revolutionary defibrillator designed to empower rescuers in providing high-quality CPR and delivering instant shock during sudden cardiac arrest (SCA) emergencies. 
• In 2024, The International Community CPR Alliance (ICCPRA) had launched its newest CPR and Basic Life Support (BLS) training center. This development signifies a major stride in ICCPRA’s mission to forge a worldwide network for the exchange of emergency medical knowledge, the training of international first responders, and the formation of community-based emergency response teams.

Why Purchase the Report?

• To visualize the global cardiopulmonary resuscitation devices market segmentation based on product type, technology, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development. 
• Excel data sheet with numerous data points of cardiopulmonary resuscitation devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global cardiopulmonary resuscitation devices market report would provide approximately 69 tables, 58 figures and 187 Pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies